Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial

References

• Strebel P, Cochi S, Grabowsky M, Bilous J, Hersh BS, Okwo-Bele JM, Hoekstra E, Wright P, Katz S. The unfinished measles immunization agenda. J Infect Dis 2003; 187(Suppl 1):S1-7; PMID:12721885; https://doi.org/10.1086/368226
   PubMed Web of Science ®Google Scholar
• Wellington K, Goa KL. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Drugs 2003; 63(19):2107-26; PMID:12962524; https://doi.org/10.2165/00003495-200363190-00012
   PubMed Web of Science ®Google Scholar
• Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet 2015; 385(9984):2297-307; PMID:25576992; https://doi.org/10.1016/S0140-6736(14)60539-0
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Progress in reducing measles mortality worldwide, 1999-2003. MMWR Morb Mortal Wkly Rep 2005; 54:200-3; PMID:15744229
   PubMedGoogle Scholar
• World Health Organization. Requirements for measles, mumps and rubella vaccines and combined vaccines (live) (requirements for biological substance no. 47). In: WHO Expert Committee on Biological Standardization. Forty-third report. Geneva: World Health Organization, 1994, Annex 3 (WHO Technical Report Series, No. 840); [accessed 2016 December 05] http://www.who.int/biologicals/publications/trs/areas/vaccines/mmr/WHO_TRS_840_A3.pdf?ua=1
   Google Scholar
• Makino S, Sasaki K, Nakayama T, Oka S, Urano T, Kimura M, Kawana R, Yamamura AM. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies. Am J Dis Child 1990; 144(8):905-10; PMID:2198807; https://doi.org/10.1001/archpedi.1990.02150320069030
   PubMedGoogle Scholar
• Nakayama T, Urano T, Osano M, Nakagawa M, Maehara N, Sasaki K, Yamamura AM, Makino S. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response. Microbiol Immunol 1990; 34(6):497-508; PMID:2120551; https://doi.org/10.1111/j.1348-0421.1990.tb03167.x
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Keshtkar A, Heshmat R, Gouya MM, Salar Amoli M, Armin S, Mahoney F. Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran. Arch Iran Med 2011; 14(2):91-5; PMID:21361714
   PubMed Web of Science ®Google Scholar
• Avijgan M, Hafizi M, Moghni M, Kheiri S, Esteghamati A, Sarikhani S. Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study. East Afr J Public Health 2011; 8(2):88-91; PMID:22066292
   PubMedGoogle Scholar
• Lee CY, Tang RB, Huang FY, Tang H, Huang LM, Bock HL. A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children. Int J Infect Dis 2002; 6(3):202-9; PMID:12718836; https://doi.org/10.1016/S1201-9712(02)90112-8
   PubMedGoogle Scholar
• Gatchalian S, Cordero-Yap L, Lu-Fong M, Soriano R, Ludan A, Chitour K, Bock HL. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age. Southeast Asian J Trop Med Public Health 1999; 30(3):511-7; PMID:10774661
   PubMedGoogle Scholar
• Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children. Pediatr Infect Dis J 2005; 24(12):1083-8; PMID:16371870; https://doi.org/10.1097/01.inf.0000183746.92218.f9
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011; 86:301-316; PMID:21766537
   PubMedGoogle Scholar
• World Health Organization. Mumps virus vaccine: WHO position paper. Wkly Epidemiol Rec 2007; 82:49-60
   Google Scholar
• MMR Vaccine - TRESIVAC [ package insert]. Pune: Serum Institute of India Ltd. 2011.
   Google Scholar
• da Cunha SS, Rodrigues LC, Barreto ML, Dourado I. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine 2002; 20(7–8):1106-12; PMID:11803071; https://doi.org/10.1016/S0264-410X(01)00438-8
   PubMed Web of Science ®Google Scholar
• Silveira CM, Kmetzsch CI, Mohrdieck R, Sperb AF, Prevots DR. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. Int J Epidemiol 2002; 31(5):978-82; PMID:12435771; https://doi.org/10.1093/ije/31.5.978
   PubMed Web of Science ®Google Scholar
• Measles virus IgG ELISA. Enzyme immunoassay for the qualitative and quantitative determination of IgG antibodies to measles virus in human serum and plasma: Instructions for use. IBL International GMBH, Hamburg Germany; 2012.
   Google Scholar
• Mumps virus IgG ELISA. Enzyme immunoassay for the qualitative and quantitative determination of IgG antibodies to measles virus in human serum and plasma: Instructions for use. IBL International GMBH, Hamburg Germany; 2012.
   Google Scholar
• Rubella virus IgG ELISA. Enzyme immunoassay for the qualitative and quantitative determination of IgG antibodies to measles virus in human serum and plasma: Instructions for use. IBL International GMBH, Hamburg Germany; 2012.
   Google Scholar
• Department of Immunization, Vaccines and Biologicals, World Health Organization. Adverse events following immunization (AEFI): Causality assessment. Geneva: World Health Organization. Available at: http://apps.who.int/iris/bitstream/10665/191391/1/a87773_eng.pdf
   Google Scholar